SERAGEN INC
NT 10-K, 1997-04-01
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: TIS MORTGAGE INVESTMENT CO, NT 10-K, 1997-04-01
Next: CORCAP INC, NT 10-K, 1997-04-01




            U.S. SECURITIES AND EXCHANGE COMMISSION
                                
                     WASHINGTON, D.C. 20549
                          FORM 12b-25
                  NOTIFICATION OF LATE FILING 
   
   
                                             0-19855              
                                             ---------------
                                             SEC FILE NUMBER
   
                                             817474-10-9
                                             ------------
          (Check One):                       CUSIP NUMBER
     
   
   
   [X] Form 10-K and Form 10-KSB  [ ] Form 20-F  [ ] Form 11-K  [ ] Form 10-Q
   and Form  10-QSB  [ ] Form N-SAR
    
   For Period Ended: December 31, 1996  
   
   [ ] Transition Report on Form 10-K
    
   [ ] Transition Report on Form 20-F
    
   [ ] Transition Report on Form 11-K
    
   [ ] Transition Report on Form 10-Q
    
   [ ] Transition Report on Form N-SAR
    
   For the Transition Period Ended: 
   N/A
   --------------------------------
   
   Read Attached Instruction Sheet Before Preparing Form. Please Print or
   Type.  
   Nothing in this form shall be construed to imply that the Commission has
   verified any  information contained herein.
    
   If the notification relates to a portion of the filing checked above,
   identify the Item(s)  to which the notification relates: 
   
   N/A
   ---------------------------------

   ========================================================================
      
   Part I--Registrant Information
   
   Full Name of Registrant:  Seragen, Inc. 
                           ---------------
   Former Name if Applicable:  N/A         
                             -------------     
   Address of Principal Executive Office (Street and Number):  
   
   97 South Street, Hopkinton, Massachusetts  01748
   ------------------------------------------------
   City, State and Zip Code
   
   ========================================================================
   <PAGE>
   Part II--Rules 12b-25 (b) and (c)
    
   If the subject report could not be filed without unreasonable effort or
   expense and the  registrant seeks relief pursuant to Rule 12b-25(b) the
   following should be  completed. (Check box if appropriate)
    
   (a) The reasons described in reasonable detail in Part III of this form
   could not be  eliminated without unreasonable effort or expense;
    
   (b) The subject annual report, semi-annual report, transition report on
   Form 10-K,  Form 20-F, 11-K or Form N-SAR, or portion thereof will be
   filed on or before the fifteenth  calendar day following the prescribed
   due date; or the subject quarterly report or  transition report on Form
   10-Q, or portion thereof will be filed on or before the fifth  calendar
   day following the prescribed due date; and
   
   (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
   has been  attached if applicable.                                          
                                  
   ========================================================================
   
   Part III--Narrative
    
   State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
   20-F,  11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or
   portion thereof could  not be filed within the prescribed period. 
   
   (Attach Extra Sheets if Needed)
   
   
        The Company is unable to file its Form 10-K for the fiscal year
        ended December 31, 1996 without unreasonable effort or expense
        because of an unforeseen emergency in the family of the Company's
        acting chief financial officer.  The Company will file the report
        within 15 calendar days of the due date.
   
   ========================================================================
   
   Part IV--Other Information
    
   (1) Name and telephone number of person to contact in regard to this
   notification  
   
   Jean C. Nichols              (508) 435-2331     
   -------------------------------------------------
       (Name)          (Area Code)(Telephone Number)
    
   (2) Have all other periodic reports required under section 13 or 15(d) of
   the Securities  Exchange Act of 1934 or section 30 of the Investment
   Company Act of 1940 during the  preceding 12 months or for such shorter
   period that the registrant was required to file  such report(s) been
   filed? If the answer is no, identify report(s).  
   [X] Yes   [ ] No
<PAGE>
    
   (3) Is it anticipated that any significant change in results of operations
   from the  corresponding period for the last fiscal year will be reflected
   by the earnings statements  to be included in the subject report or
   portion thereof?  
   [ ] Yes   [X] No
    
   If so: attach an explanation of the anticipated change, both narratively
   and quantitatively, and, if appropriate, state the reasons why a
   reasonable estimate of the  results cannot be made.
    
   Seragen, Inc.
   --------------------------------------------
   (Name of Registrant as specified in charter)
    
   has caused this notification to be signed on its behalf by the undersigned
   thereunto duly authorized.
    
   Date:  March 31, 1997      By:   /s/ Jean C. Nichols, Ph.D.                 
                                   --------------------------
                                   Jean C. Nichols, Ph.D.
                                   President
   
   INSTRUCTION: The form may be signed by an executive officer of the
   registrant or by  any other duly authorized representative. The name and
   title of the person signing the  form shall be typed or printed beneath
   the signature. If the statement is signed on behalf  of the registrant by
   an authorized representative (other than an executive officer),  evidence
   of the representative's authority to sign on behalf of the registrant
   shall be filed with the form.
   
   
   
   ATTENTION
    
   Intentional misstatements or omissions of fact constitute Federal Criminal
   Violations  (See 18 U.S.C. 1001).
   
   
   GENERAL INSTRUCTIONS
    
   1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
   Rules and  Regulations under the Securities Exchange Act of 1934.
    
   2. One signed original and four conformed copies of this form and
   amendments  thereto must be completed and filed with the Securities and
   Exchange Commission,  Washington, D.C. 20549, in accordance with Rule 0-3
   of the General Rules and  Regulations under the Act. The information
   contained in or filed with the Form will be  made a matter of the public
   record in the Commission files.  
   
   3. A manually signed copy of the form and amendments thereto shall be
   filed with  each national securities exchange on which any class of
   securities of the registrant is  registered.
    
   4. Amendments to the notifications must also be filed on Form 12b-25 but
   need not  restate information that has been correctly furnished. The form
   shall be clearly identified  as an amended notification.
    
   5. Electronic Filers. This form shall not be used by electronic filers
   unable to timely  file a report solely due to electronic difficulties.
   Filers unable to submit a report within  the time period prescribed due to
   difficulties in electronic filing should comply with  either Rule 201 or
   Rule 202 of Regulation S-T (232.201 or 232.202 of this chapter) or  apply
   for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T 
   (232.13(b) of this chapter).
    
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission